Your browser doesn't support javascript.
loading
The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-γ and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase.
Lim, Ji-Young; Kim, Byung-Su; Ryu, Da-Bin; Kim, Tae Woo; Park, Gyeongsin; Min, Chang-Ki.
Afiliación
  • Lim JY; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim BS; Department of Hematology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 1021 Tongil Ro, Eunpyeong-gu, Seoul, 03312, Republic of Korea. luke.kbs@gmail.com.
  • Ryu DB; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim TW; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Park G; Department of Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Min CK; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Stem Cell Res Ther ; 12(1): 37, 2021 01 07.
Article en En | MEDLINE | ID: mdl-33413597

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis / Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Stem Cell Res Ther Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis / Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Stem Cell Res Ther Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido